Content area

|
|

Cancer under graviditeten

Forfatter(e)
Berit Woetmann Pedersen1, Lone Storgaard2, Mette Borg Clausen3, Niels Kroman4, Jens Langhoff-Roos1 & Karina Dahl Steffensen5 1) Obstetrisk Klinik, Rigshospitalet 2) Gynækologisk Obstetrisk Afdeling, Aarhus Universitets-hospital 3) Hæmatologisk Klinik, Rigshospitalet 4) Brystkirurgisk Sektion, Klinik for Plastikkirurgi, Brystkirurgi og Brandsårsbehandling, Rigshospitalet 5) Onkologisk Afdeling, Sygehus Lillebælt Ugeskr Læger 2015;177:V12140714
Reference: 
Ugeskr Læger 2015;177:V12140714
Blad nummer: 
Sidetal: 
2-6
Cancer in pregnancy
Cancer in pregnancy occurs in about one in 1,000 pregnancies. Recent reports have shown that most treatment regimes in second and third trimester are safe for the mother and the child. This has led to a paradigm shift in treating pregnant women with cancer. The management of the pregnant woman should be in a multidisciplinary setting, and delivery should be postponed to avoid very preterm delivery and planned 2-3 weeks after the last chemotherapeutic treatment allowing both maternal and foetal bone marrow to recover.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Anna Birthe Holmehøj Bach | 04/12
1 Kommentar
af Susanne L. M. Bülow | 03/12
1 Kommentar
af Andreas Gothardt Lundh | 02/12
1 Kommentar
af Michael Uldall Steinfath | 01/12
1 Kommentar
af Pedram Kazemi-Esfarjani | 01/12
1 Kommentar
af Bjarne Stigsby | 30/11
2 kommentarer
af Camilla Bang | 29/11
2 kommentarer
af Stine Madsen-Østerbye | 29/11
1 Kommentar